<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Parasitol</journal-id>
      <journal-title-group>
        <journal-title>International Journal for Parasitology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0020-7519</issn>
      <issn pub-type="epub">1879-0135</issn>
      <publisher>
        <publisher-name>Elsevier Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3034870</article-id>
      <article-id pub-id-type="pmid">20858498</article-id>
      <article-id pub-id-type="publisher-id">PARA3197</article-id>
      <article-id pub-id-type="doi">10.1016/j.ijpara.2010.08.008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Whole genome re-sequencing identifies a mutation in an ABC transporter (<italic>mdr2</italic>) in a <italic>Plasmodium chabaudi</italic> clone with altered susceptibility to antifolate drugs<sup><xref ref-type="fn" rid="d30e876">☆</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Martinelli</surname>
            <given-names>Axel</given-names>
          </name>
          <email>amartinelli@ihmt.unl.pt</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Henriques</surname>
            <given-names>Gisela</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cravo</surname>
            <given-names>Pedro</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hunt</surname>
            <given-names>Paul</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Centro de Malaria e Outras Doenças Tropicais/IHMT/UEI Biologia Molecular, Universidade Nova de Lisboa, Rua da Junqueira 96, 1349-008 Lisbon, Portugal</aff>
      <aff id="aff2"><label>b</label>Institute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK</aff>
      <aff id="aff3"><label>c</label>Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Tel.: +351 213 622458. <email>amartinelli@ihmt.unl.pt</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>41</volume>
      <issue>2</issue>
      <fpage>165</fpage>
      <lpage>171</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>7</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>8</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier Ltd.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Australian Society for Parasitology Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical abstract</title>
          <p>■■■.<fig id="f0030" position="anchor"><graphic xlink:href="fx1"/></fig></p>
        </sec>
        <sec>
          <title>Research highlights</title>
          <p>► A pyrimethamine+sulphadoxine-resistant rodent malaria genome was sequenced. ► Its genome sequence was compared with that of a sensitive progenitor. ► Four point mutations were identified: on chromosomes 2, 7, 13 and 14. ► The K392Q mutation in <italic>mdr2</italic> is genetically linked to sulphadoxine resistance. ► <italic>mdr2</italic> is a novel candidate gene underlying antifolate resistance in malaria.</p>
        </sec>
      </abstract>
      <abstract>
        <p>In malaria parasites, mutations in two genes of folate biosynthesis encoding dihydrofolate reductase (<italic>dhfr</italic>) and dihydropteroate synthase (<italic>dhps</italic>) modify responses to antifolate therapies which target these enzymes. However, the involvement of other genes which modify the availability of exogenous folate, for example, has been proposed. Here, we used short-read whole-genome re-sequencing to determine the mutations in a clone of the rodent malaria parasite, <italic>Plasmodium chabaudi</italic>, which has altered susceptibility to both sulphadoxine and pyrimethamine. This clone bears a previously identified S106N mutation in <italic>dhfr</italic> and no mutation in <italic>dhps</italic>. Instead, three additional point mutations in genes on chromosomes 2, 13 and 14 were identified. The mutated gene on chromosome 13 (<italic>mdr2</italic> K392Q) encodes an ABC transporter. Because Quantitative Trait Locus analysis previously indicated an association of genetic markers on chromosome 13 with responses to individual and combined antifolates, MDR2 is proposed to modulate antifolate responses, possibly mediated by the transport of folate intermediates.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>
          <italic>Plasmodium</italic>
        </kwd>
        <kwd>Sulphadoxine</kwd>
        <kwd>Folate</kwd>
        <kwd>Mutation</kwd>
        <kwd>
          <italic>mdr2</italic>
        </kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>With the evolution of chloroquine resistance in malaria parasites in Africa and southeast Asia, the combination of the antifolate drugs pyrimethamine (PYR) and sulphadoxine (SDX), commercially known as Fansidar®, was one of the mainstays of anti-malarial drug therapy. Although resistance is now widespread, it is still used in Africa, sometimes in combination with the artemisinin derivative artesunate, to treat uncomplicated malaria (<xref rid="b0150" ref-type="bibr">Nosten and White, 2007</xref>). PYR and SDX synergistically inhibit enzyme activities of the folate biosynthesis pathway, namely dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS), both encoded in bifunctional enzymes by <italic>dhfr-ts</italic> and <italic>pppk-dhps</italic>, respectively (<xref rid="s0065" ref-type="sec">Supplementary Fig. S1</xref>). The folate pathway plays a critical role in pyrimidine and DNA synthesis. The action of antifolate drugs, the genetic basis of parasite resistance, and the complexities of the relationships between parasite genotype and in vivo and in vitro drug response phenotypes have been comprehensively investigated (reviewed in <xref rid="b0065 b0085 b0155" ref-type="bibr">Gregson and Plowe, 2005; Hyde, 2005; Nzila, 2006</xref>).</p>
      <p>Four point mutations in <italic>dhfr</italic> have been associated with the development of PYR resistance in the human malaria parasite <italic>Plasmodium falciparum</italic>. The S108N point mutation is crucial for the initial acquisition of PYR resistance: it interferes with the kinetics of PYR binding to DHFR (<xref rid="b0065 b0085 b0155" ref-type="bibr">Gregson and Plowe, 2005; Hyde, 2005; Nzila, 2006</xref>). Subsequent mutations (N51I, C59R and I164L) are thought to further increase resistance (<xref rid="b0165 b0005 b0195 b0160" ref-type="bibr">Peterson et al., 1988; Basco et al., 1995; Sirawaraporn et al., 1997; Nzila-Mounda et al., 1998</xref>). Transfection studies show that the S108N mutation reduces the response of malaria parasites to PYR (<xref rid="b0230" ref-type="bibr">Wu et al., 1996</xref>). In populations of <italic>P. falciparum</italic> field isolates from Thailand, Laos and central Africa, selective sweeps have been documented around <italic>dhfr</italic> on chromosome 4, where genetic hitchhiking has reduced genetic diversity in PYR-resistant parasites relative to susceptible parasites (<xref rid="b0130 b0140 b0120" ref-type="bibr">Nair et al., 2003; Nash et al., 2005; McCollum et al., 2008</xref>).</p>
      <p>SDX is an analogue of 4-aminobenzoic acid (pABA) – a substrate of DHPS (<xref rid="s0065" ref-type="sec">Supplementary Fig. S1</xref>). SDX resistance has been linked with several point mutations on the <italic>pppk-dhps</italic> gene: S436A, A437G, K540E, A581G and A613S,T (<xref rid="b0200 b0170 b0205 b0220" ref-type="bibr">Triglia and Cowman, 1994; Plowe et al., 1997; Triglia et al., 1997; Wang et al., 1997</xref>). A number of <italic>dhps</italic> allele combinations were tested in <italic>P. falciparum</italic> by transfection, confirming their role in SDX responses (<xref rid="b0210" ref-type="bibr">Triglia et al., 1998</xref>). However, a number of factors have impeded a clear formal association between mutations in <italic>dhps</italic> and in vitro SDX and SDX/PYR (S/P) responses. For example, the SDX response phenotype may depend upon the availability of exogenous folate and pABA (<xref rid="b0125 b0105 b0220 b0225" ref-type="bibr">Milhous et al., 1985; Krungkrai et al., 1989; Wang et al., 1997, 1999</xref>), presumably because exogenous folate ‘bypasses’ the requirement for DHPS activity (the ‘folate effect’; <xref rid="b0220" ref-type="bibr">Wang et al., 1997</xref>), and because pABA can compete with SDX. It is also likely that other genes effect SDX (or S/P) responses. For example, the acquisition of PYR resistance by <italic>dhfr</italic> mutation may increase susceptibility to SDX (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>). Also, other genes may be linked to the ‘folate effect’ (<xref rid="b0220" ref-type="bibr">Wang et al., 1997</xref>); for example, it has been proposed that mutations in the multi-drug resistance protein 1 (MRP1) may contribute to S/P resistance (<xref rid="b0040" ref-type="bibr">Dahlström et al., 2009</xref>), possibly mediated by decreases in folate efflux from the parasite. There have been other reports of SDX or S/P resistance appearing without the apparent involvement of <italic>dhps</italic> mutation in both human and rodent malaria (<xref rid="b0070 b0115" ref-type="bibr">Hayton et al., 2002; Mberu et al., 2000</xref>). This paper addresses the possible identities of such genes.</p>
      <p>The rodent malaria parasite <italic>Plasmodium chabaudi</italic> has been used as an in vivo experimental model for the generation of drug-resistant mutants by experimental evolution and the identification of the genes conferring the drug-resistance phenotypes (<xref rid="b0015" ref-type="bibr">Carlton et al., 2001</xref>). For example, the mutation conferring PYR resistance in the experimentally selected AS-PYR clone (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) is S106N <italic>dhfr</italic> (<xref rid="b0025 b0020 b0035" ref-type="bibr">Cowman and Lew, 1990; Cheng and Saul, 1994; Culleton et al., 2005</xref>): this mutation is homologous to S108N in <italic>P. falciparum</italic>. As also reported in <italic>P. falciparum</italic> (<xref rid="b0050" ref-type="bibr">Eastham and Rieckmann, 1983</xref>), the acquisition of PYR resistance in <italic>P. chabaudi</italic> is accompanied by an increase in susceptibility to SDX (<xref rid="b0090 b0070" ref-type="bibr">Jacobs, 1964; Hayton et al., 2002</xref>). Subsequently, a single-step exposure of the AS-PYR clone to a high dose of S/P selected a mutant clone (AS-50S/P) which is more resistant to both S/P and SDX (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>) than the AS-PYR progenitor (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). These phenotypes are genetically stable. AS-50S/P has no mutation in the <italic>dhps</italic> gene, nor additional mutations in the <italic>dhfr</italic> gene (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>). In order to map the genes underlying the modified drug response phenotypes, Quantitative Trait Locus (QTL) analysis of 16 independent cloned recombinant progeny of a genetic cross between the resistant parent AS-50S/P and the genetically distinct susceptible parent AJ suggested that loci on chromosomes 7 and 13 (chr07 and chr13) are associated with PYR, SDX and S/P responses (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>). As expected, for chr07 (containing <italic>dhfr</italic>), growth after PYR treatment (and S/P) was associated with the inheritance of the mutant AS allele: growth following SDX treatment was associated with inheritance of wild-type AJ alleles. For chr13 markers, growth during SDX treatment was associated with inheritance of AS alleles, whilst for PYR and S/P, growth was associated with inheritance of AJ alleles.</p>
      <p>Those data suggested that a mutation on chr13 in AS-50S/P relative to AS-PYR increased the SDX resistance (of a PYR-resistant parasite). Here, we have re-sequenced the whole genome of the SDX-resistant clone of <italic>P. chabaudi</italic> (AS-50S/P) using Solexa paired-end short reads to identify point mutations, small indels (⩽3 bp) and, for key genes, copy number variations (CNVs) too.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Parasite lines, maintenance, parasite preparation and DNA extraction</title>
        <p><italic>Plasmodium chabaudi</italic> clone AS-50S/P of the AS-lineage (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>; <xref rid="f0005" ref-type="fig">Fig. 1</xref>) was routinely inoculated, passaged in CBA mice (4–6 weeks) and cryopreserved as previously described (<xref rid="b0215" ref-type="bibr">Walliker et al., 1975</xref>). Parasites were prepared and DNA extracted as previously described (<xref rid="b0060" ref-type="bibr">Grech et al., 2002</xref>), ensuring that host white cells were removed by CF11 cellulose (Whatman, UK) and Plasmodipur filters (Eurodiagnostica, The Netherlands).</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Illumina Solexa genome re-sequence analysis</title>
        <p>Clone AS-sens was previously re-sequenced using the Illumina® (Solexa) platform with 36 bp single reads (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>), while clone AS-50S/P was sequenced for this study using 50 bp paired-end reads, at a mean genome coverage of approximately 45 reads per nucleotide. Individual sequence strings (reads) from each clone were aligned against an isogenic AS reference sequence (AS-WTSI (<xref rid="f0005" ref-type="fig">Fig. 1</xref>), provided by the Pathogen Sequencing Group, Wellcome Trust Sanger Institute, UK) using two different software packages; MAQ (Mapping and Assembly with Quality; <xref rid="b0110" ref-type="bibr">Li et al., 2008</xref>) and SSAHA2 (Sequence Search and Alignment by Hashing Algorithm; <xref rid="b0145" ref-type="bibr">Ning et al., 2001</xref>). A permissive insert size range (40–500 bp) was chosen for the alignment of paired-end reads. The AS-WTSI sequence data consisted of a recently completed assembly and annotation made available during this investigation (<ext-link ext-link-type="uri" xlink:href="http://ftp.sanger.ac.uk/pub/pathogens/P_chabaudi/September_2009_assembly/">ftp://ftp.sanger.ac.uk/pub/pathogens/P_chabaudi/September_2009_assembly/</ext-link>). The detection of single nucleotide polymorphisms (SNPs) was performed using MAQ and SSAHA2, as described previously, with a minimum coverage of three reads chosen to call a potential SNP prior to further quality analysis (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>). Lists obtained for AS-sens and AS-50S/P were compared in order to remove candidate SNPs which did not arise within the lineage. All putative point mutations proposed by MAQ and/or SSAHA2 were verified by di-deoxy sequencing.</p>
        <p>Small indels (⩽3 bp) were predicted using the internal algorithm of SSAHA2. The potential indel list was filtered against a list previously obtained for clone AS-sens (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>), in order to remove calls not unique to AS-50S/P. A limited number of the small indel calls were investigated by di-deoxy sequencing.</p>
        <p>No genome-wide large indel or CNV prediction was attempted using SSAHA2 because no appropriately sequenced (i.e., using paired-end reads) AS-sens genome was available to act as a “filter” (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>) to remove the large number of candidates which are not exclusive to the mutant clone.</p>
        <p>However, a list of potential indels (including indels &gt;3 bp) was produced using the internal MAQ prediction algorithm. This algorithm is only available for genomes sequenced using paired-end reads. Again, no appropriate “filter” could be used to remove those indels not unique to AS-50S/P. However, the list of small indels obtained with MAQ was compared with the small indel predictions of SSAHA2. Three large indels were predicted with MAQ and these were retained as candidates.</p>
        <p>To detect gene amplifications, the fold-coverage of sequence reads mapping to individual genes was measured using Artemis (<xref rid="b0185" ref-type="bibr">Rutherford et al., 2000</xref>) and the coverage plot obtained from SSAHA2 (see <xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>). The gene-specific average fold-coverage was divided by the mean genome coverage to produce a “relative coverage” in AS-sens and AS-50S/P. A “comparative coverage” index was produced by dividing the relative coverage of the mutant clone by that of AS-sens. If the “comparative coverage” index was &gt;1.5 it was taken as evidence of gene amplification. A known gene duplication in the multi-drug resistance gene 1 (<italic>mdr1</italic>, PCHAS_123820) in a clone previously selected for mefloquine resistance (AS-15MF; <xref rid="b0030" ref-type="bibr">Cravo et al., 2003</xref>) and which has also been Solexa sequenced (unpublished data) was used as a positive control.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Protein function prediction</title>
        <p>Information on predicted proteins was extracted from the PlasmoDB database (<ext-link ext-link-type="uri" xlink:href="http://www.plasmodb.org/">http://www.plasmodb.org/</ext-link>) for all mutations confirmed by di-deoxy sequencing. In the case of hypothetical proteins, the amino acid sequences were submitted to Pfam (<ext-link ext-link-type="uri" xlink:href="http://www.pfam.sanger.ac.uk">http://www.pfam.sanger.ac.uk</ext-link>) and Prosite (<ext-link ext-link-type="uri" xlink:href="http://www.expasy.ch/prosite/">http://www.expasy.ch/prosite/</ext-link>) for the identification of protein domains, functional sites and protein families. HMMTOP (<ext-link ext-link-type="uri" xlink:href="http://www.enzim.hu/hmmtop/">http://www.enzim.hu/hmmtop/</ext-link>) was used for the prediction of transmembrane domains.</p>
      </sec>
    </sec>
    <sec id="s0030">
      <label>3</label>
      <title>Results</title>
      <sec id="s0035">
        <label>3.1</label>
        <title>Genome re-sequencing</title>
        <p>The genome of clone AS-50S/P was sequenced as 50 bp paired-end reads using the Illumina short read sequencing platform (Solexa). These reads were mapped against the reference genome (assembly of September 2009, see Section <xref rid="s0020" ref-type="sec">2.2</xref>) using two software packages: MAQ (<xref rid="b0110" ref-type="bibr">Li et al., 2008</xref>) and SSAHA2 (<xref rid="b0145" ref-type="bibr">Ning et al., 2001</xref>). In total, 19,132,804 short paired-end reads were produced. Ninety percent of those reads mapped to the genome in MAQ and 92% in SSAHA2. Of those, 17,943,606 (i.e., approximately 90% of the total reads) mapped uniquely to the reference genome in SSAHA2. The average length of the paired-end read intervals was 207 bp with the frequency distribution shown in <xref rid="s0065" ref-type="sec">Supplementary Fig. S2</xref>. Eighty-nine percent of the nucleotides in the genome were covered by at least 10 reads in SSAHA2. The scaffolded assembly yielded an average genome-wide read coverage of 47.0 or 44.4 reads per nucleotide (MAQ and SSAHA2, respectively).</p>
      </sec>
      <sec id="s0040">
        <label>3.2</label>
        <title>SNP detection</title>
        <p>Both MAQ and SSAHA2 were used to call SNPs. SNP calls were filtered against an equivalent list of SNPs identified by Solexa re-sequencing of the susceptible progenitor clone AS-sens (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>) in order to produce a list of predicted mutations arising in the lineage between AS-sens and AS-50S/P. Four point mutations were identified by both MAQ and SSAHA2. They appear on chr02, chr07, chr13 and chr14 (<xref rid="t0005" ref-type="table">Table 1</xref>). They include non-synonymous substitutions in <italic>dhfr</italic> (chr07, S106N PCHAS_072830, SSAHA quality score 99), in a gene encoding an ABC transporter, multi-drug resistance protein 2 (MDR2), (chr13, K392Q PCHAS_131500, quality score 47), in a gene encoding a small conserved protein (chr02, E109G PCHAS_020660, quality score 99), and an intergenic mutation (T936,945G) lying between two genes coding for two conserved <italic>Plasmodium</italic> proteins (chr14, PCHAS_142590 and PCHAS_142600, quality score 40). The gene identifications (IDs) and their presumed orthologues in <italic>P. falciparum</italic> are given in <xref rid="t0005" ref-type="table">Table 1</xref>. Those four mutations were confirmed by amplification and di-deoxy sequencing, and their origin within the AS lineage determined by sequencing AS-sens, AS-PYR1 and AS-50S/P (<xref rid="f0005" ref-type="fig">Fig. 1</xref>).</p>
        <p>DHFR S106N has previously been characterised (<xref rid="b0025 b0020" ref-type="bibr">Cowman and Lew, 1990; Cheng and Saul, 1994</xref>) and arises, as expected, in AS-PYR1 during PYR selection. The intergenic point mutation on chr14 (T936,945G) was confirmed by dideoxy sequencing as appearing first in AS-PYR1. Consultation of the PlasmoDB and PlasmoPredict databases, as well as a search for matches on the Pfam and Prosite search engines, did not yield any significant hits pointing to a potential function for the two proteins flanking this mutation.</p>
        <p>The point mutation on chr02 on the other hand was confirmed as arising in AS-50S/P during selection by S/P. No functional predictions were made for the mutated gene (PCHAS_020660) and the E109G mutation could not be placed within any recognised protein domain.</p>
        <p>On chr13, MDR2 K392Q also arises in AS-50S/P during selection by S/P. The mutation is located within the fifth of 10 predicted transmembrane domains of this putative ABC transporter (ABCB3; <xref rid="b0190" ref-type="bibr">Sauvage et al., 2009</xref>) protein. It substitutes a neutral polar glutamine for a positively charged lysine. Importantly, previous QTL analysis of the AS-50S/P × AJ genetic cross showed that genetic markers mapping to chr13 were linked to SDX resistance (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>). Specifically, on chr13, <italic>mdr2</italic> maps between those markers most closely linked to SDX resistance: it lies approximately 100 kb downstream of marker <italic>aldoI</italic> (currently annotated as fructose-bisphosphate aldolase, PCHAS_131180, located approximately at position 510,000) and 200 kb upstream to marker <italic>g6pdh</italic> (glucose-6-phosphate dehydrogenase, PCHAS_132080, located approximately at position 829,000) (<xref rid="s0065" ref-type="sec">Supplementary Fig. S3</xref>)<italic>.</italic> In order to estimate the likelihood that a potential point mutation in the proximity may have been missed due to insufficient read coverage, a region spanning 400 kb upstream and downstream of the <italic>mdr2</italic> gene was selected and the proportion of nucleotides within this area that were covered by less than three reads (i.e., the minimum for calling a SNP in both SSAHA2 and MAQ) was estimated as 0.4%. Across the whole of chr13, this proportion rose to 1.4%. Both values indicate a very low likelihood of any SNP having been missed on chr13 due to insufficient coverage, and strongly suggest that the mutation on <italic>mdr2</italic> is the sole mutation linked with the SDX-resistant phenotype.</p>
        <p>Four additional low quality SNP calls were made by SSAHA2 only (<xref rid="t0005" ref-type="table">Table 1</xref>). Excluding a putative point mutation on chr14 (T711,800G, coverage 11, quality score 37), the remaining calls were both of lower quality and lower coverage than the SNPs identified by both MAQ and SSAHA2. One call on chr14 (T951,458A) had a quality score of 10 and a read depth of 3. Both of these chr14 calls were negated by PCR and di-deoxysequencing, and therefore deemed as false-positives. The remaining two calls, namely A107,354C (read coverage of 5 and quality score of 25) and T411,999C (read coverage of 4 and quality score of 14) mapped to a composite “chromosome” of contigs not yet located to any chromosome (“bin”) and lay within or near to genes coding for members of the <italic>chabaudi</italic> Interspersed Repeat (<italic>cir</italic>) family. These two point mutations could not be verified by di-deoxy sequencing because relevant DNA fragments could not be amplified. No SNP calls were uniquely proposed by MAQ.</p>
      </sec>
      <sec id="s0045">
        <label>3.3</label>
        <title>Indel detection</title>
        <p>SSAHA2 was used to identify small indels (⩽3 bp), which were further confirmed by MAQ analysis. Potential large indels (&gt;3 bp) were only predicted through MAQ, due to the lack of an appropriately re-sequenced (i.e., with paired-end reads) susceptible parent AS-sens to act as a filter for the SSAHA2-based analysis (see <xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>). A total of 62 indels were predicted (see <xref rid="s0065" ref-type="sec">Supplementary Table S1</xref>). Fifty-eight were classified as small indels, while four were classified as large indels. <xref rid="t0005" ref-type="table">Table 1</xref> shows the 11 indels that were either confirmed (green), rejected (red) by di-deoxy sequencing or those that were considered as being high confidence mutations (yellow), based on read coverage and SSAHA2 quality scores as described previously (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>). All large indels, with one exception (see below in this section) were classified as low confidence mutations, due to the lack of appropriate filtering in the MAQ analysis (see Section <xref rid="s0020" ref-type="sec">2.2</xref>).</p>
        <p>Only two indels (a 1 bp deletion at position 290,663 on chr10 and a 1 bp insertion at position 2,070,154 on chr14) were identified by SSAHA2 and MAQ (<xref rid="t0005" ref-type="table">Table 1</xref> and <xref rid="s0065" ref-type="sec">Supplementary Table S1</xref>). Di-deoxy sequencing of the deletion on chr10 indicated that this call was a false positive. Of the remaining indels, only one was analysed by di-deoxy sequencing (a single nucleotide insertion at position 854,448 on chr08) and rejected as a false positive (<xref rid="t0005" ref-type="table">Table 1</xref>). No further re-sequencing was undertaken, but due to the large number of indels compared with point mutations and previous experience with a similar data set (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>) it is predicted that the vast majority of these calls will be false positives.</p>
        <p>One indel that was not predicted by the MAQ algorithm was verified in the course of this study. Its presence was predicted based on previous whole-genome re-sequencing analysis (and validation) of related clones of the same lineage, using a comparative coverage approach based on the SSAHA2 software (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>); an approach which could not be applied here due to the lack of a paired-end sequenced AS-sens genome for comparison. The 34 bp deletion (located between positions 876,894 and 876,927 on chr7) was verified by di-deoxy sequencing (<xref rid="t0005" ref-type="table">Table 1</xref>). This deletion falls immediately downstream (and 3′) of a gene encoding a conserved <italic>Plasmodium</italic> protein (PCHAS_072420, homologous to PF08_0067 in <italic>P. falciparum</italic>), which contains four transmembrane domains, a signal peptide and a ubiquitin-like fragment. It is also located upstream (and 5′) of a putative eukaryotic translation factor (PCHAS_072430, homologous to MAL8P1.83 in <italic>P. falciparum</italic>).</p>
      </sec>
      <sec id="s0050">
        <label>3.4</label>
        <title>CNV detection</title>
        <p>Gene copy number variation in <italic>dhfr</italic> and GTP cyclohydrolase have been identified (<xref rid="b0025 b0095" ref-type="bibr">Cowman and Lew, 1990; Kidgell et al., 2006</xref>) and may modulate responses to antifolate drugs. We investigated the copy numbers of genes encoding enzymes of the folate biosynthetic pathway (<xref rid="s0065" ref-type="sec">Supplementary Fig. S1</xref>) using a validated analysis of the coverage of Solexa reads in these genes. <xref rid="t0010" ref-type="table">Table 2</xref> shows that the relative read-coverages for GTP cyclohydrolase I, 6-pyruvoyltetrahydropterin synthase, <italic>dhps</italic>, dihydrofolate synthase, <italic>dhfr</italic> and serine hydroxymethyltransferase were no different in AS-50S/P compared with AS-sens. In contrast, the relative read coverage for <italic>mdr1</italic> in AS-15MF (<xref rid="b0030" ref-type="bibr">Cravo et al., 2003</xref>) was twice that in AS-sens, reflecting the previously known duplication in that clone.</p>
      </sec>
    </sec>
    <sec id="s0055">
      <label>4</label>
      <title>Discussion</title>
      <p>Of the four point mutations identified, two, namely S106N <italic>dhfr</italic> (chr07) and the intergenic point mutation on chr14 were already present in the PYR-resistant progenitor clone, AS-PYR1.</p>
      <p>Two point mutations occurred between AS-PYR and the S/P-resistant clone, AS-50S/P. These are located on chr02 and chr13. There were no further mutations in <italic>dhps</italic> or other known folate genes which might account for the increased resistance to SDX in AS-50S/P. These data support a previous study which identifies a small number of point mutations accumulating during the evolution of other complex drug resistance phenotypes (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>) and confirms how this model and technology are well suited for complete genome re-sequencing of isogenic strains of <italic>P. chabaudi</italic> and identification of critical mutations conferring drug-resistance phenotypes.</p>
      <p>Of these three mutations, that located on chr13 is most significant to SDX responses because two genetic markers most linked to SDX responses in QTL analysis mapped to chr13 (<xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>). These markers (numbers 19 and 37; <xref rid="b0070" ref-type="bibr">Hayton et al., 2002</xref>) map to <italic>g6pdh</italic> (PCHAS_132080) and fructose-bisphosphate aldolase (PCHAS_131180), respectively (<xref rid="b0010" ref-type="bibr">Carlton et al., 1998</xref>). The K392Q MDR2 mutation maps between these two markers (<xref rid="s0065" ref-type="sec">Supplementary Fig. S3</xref>), ∼216 kb upstream of the former and ∼104 kb downstream of the latter. Because no other mutations were indicated on this chromosome, we propose that the mutant AS <italic>mdr2</italic> allele contributes to increased resistance to SDX.</p>
      <p>In <italic>P. falciparum</italic>, increased resistance to SDX in PYR-resistant parasites often involves mutations in <italic>dhps</italic>, but other mechanisms may exist. For example, SDX-resistant <italic>P. falciparum</italic> isolates with wild-type <italic>dhps</italic> sequences have been characterised (<xref rid="b0115" ref-type="bibr">Mberu et al., 2000</xref>). Furthermore, recent work by <xref rid="b0040" ref-type="bibr">Dahlström et al. (2009)</xref> has suggested that mutations (I876V and K1466R) in the multi-drug resistance protein 1 (encoded by <italic>mrp1</italic> (PFA0590w) may mediate an alternative mechanism modulating S/P resistance. For example, they propose that this mutation may result in higher concentrations of exogenous folate being made available for the cell. Here, we identify mutations in MDR2, another ABC transporter (<xref rid="b0100 b0175 b0190" ref-type="bibr">Klokouzas et al., 2003; Rosenberg et al., 2006; Sauvage et al., 2009</xref>), which may function similarly.</p>
      <p>In <italic>P. falciparum</italic>, MDR2 (PF14_0455) is characterised as an ABCB (pfABCB3) transporter (<xref rid="b0190" ref-type="bibr">Sauvage et al., 2009</xref>) belonging to the same subfamily as MDR1 (PFE1150w, pfABCB1) but distinct from the MRP1 transporter (PFA0590w, PfABCC1) investigated by <xref rid="b0040" ref-type="bibr">Dahlström et al. (2009)</xref>, which belongs to the ABCC subfamily of ABC transporters. MDR2 is located both in the plasma membrane of the parasite as well as in the food vacuole membrane and contains 10 transmembrane domains and a single nucleotide binding site (<xref rid="b0240 b0180" ref-type="bibr">Zalis et al., 1993; Rubio and Cowman, 1994</xref>). It is related to the MDR1 ABC transporter implicated in resistance to multiple anti-malarial drugs, notably mefloquine (<xref rid="b0045" ref-type="bibr">Duraisingh and Cowman, 2005</xref>). MDR2 is associated with heavy metal ion efflux and resistance to cadmium (<xref rid="b0175" ref-type="bibr">Rosenberg et al., 2006</xref>) but evidence of its involvement in responses to anti-malarial drugs is weak or conflicting (<xref rid="b0055 b0180 b0235" ref-type="bibr">Ekong et al., 1993; Rubio and Cowman, 1994; Wurtz et al., 2010</xref>). MDR2 may be involved in the transport of organic anions, such as folate or pABA, as suggested for MRP1 (<xref rid="b0040" ref-type="bibr">Dahlström et al., 2009</xref>), and due to the structural similarity between pABA and sulphadoxine, the transport of SDX too. Independently of the actual mechanism by which MDR2 mediates SDX resistance, its role in SDX-resistant <italic>P. falciparum</italic> strains with wild-type <italic>dhps</italic> sequences (<xref rid="b0115" ref-type="bibr">Mberu et al., 2000</xref>) may now be evaluated. The role of <italic>mdr2</italic> mutations in generating SDX resistance might also be experimentally investigated using transfection approaches in either <italic>P. chabaudi</italic> or <italic>P. falciparum</italic>.</p>
      <p>Previous Solexa analysis of other clones of the AS lineage of <italic>P. chabaudi</italic> parasites identified a 34 bp deletion on chr07 located ∼120 kb upstream of <italic>dhfr</italic> (<xref rid="b0080" ref-type="bibr">Hunt et al., 2010</xref>). This mutation is present in AS-PYR1 but not AS-sens. Its relationship to PYR resistance or to possible fitness costs of a <italic>dhfr</italic> mutation is not known. It is located 47 bp downstream of the 3′ end of a gene (PCHAS_072420, orthologous to PF08_0067) that encodes a conserved <italic>Plasmodium</italic> spp. protein of unknown function. This protein is predicted to contain four transmembrane domains and a signal peptide. Previous genetic linkage data from a genetic cross between the <italic>P. falciparum</italic> clones Dd2 and HB3 (with different <italic>dhfr</italic> and <italic>dhps</italic> alleles) and sequence analysis of other <italic>P. falciparum</italic> isolates suggest the possibility that the ‘folate effect’ was associated with a gene closely linked to <italic>dhfr</italic> (<xref rid="b0220" ref-type="bibr">Wang et al., 1997</xref>).</p>
      <p>Despite the apparent simplicity of the drug/target interactions in the folate pathway, the patterns of antifolate drug susceptibility can be complex. We note that Metabolic Control Analysis (<xref rid="b0075" ref-type="bibr">Hornberg et al., 2007</xref>) provides a conceptual framework for understanding the distributed control of flux within metabolic pathways (in contrast to the construct ‘rate-limiting step’). In folate biosynthesis, the control of pathway flux may be shared between <italic>dhps</italic> activity and <italic>dhfr</italic> activity (and other activities, such as folate transporters or GTP cyclohydrolase activity; <xref rid="b0095 b0135" ref-type="bibr">Kidgell et al., 2006; Nair et al., 2008</xref>), and that this distribution may change as mutations in <italic>dhps</italic> or <italic>dhfr</italic> accumulate and the kinetic parameters of the enzymes change. The synergistic action of SDX and PYR, the increased susceptibility to SDX when <italic>dhfr</italic> mutations generate PYR resistance, the ‘folate effect’ and the role of mutations in putative folate transporters may be more clearly understood with such a theoretical framework.</p>
      <p>To summarise, our analysis revealed several mutations in a clone of <italic>P. chabaudi</italic> selected for resistance by SDX–PYR drug treatment. In particular, a non-synonymous substitution on the gene encoding MDR2 was identified and found to correlate with markers previously described as being associated with SDX resistance. It is proposed that <italic>mdr2</italic> may underlie the SDX resistance phenotype either by directly mediating transport of the drug itself or indirectly by mediating the transport of exogenous folate (or pABA) which may counteract the activity of SDX (the so-called ‘folate effect’).</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b0005">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basco</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Eldin de Pecoulas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Le Bras</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mazabraud</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in <italic>Plasmodium falciparum</italic></article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>69</volume>
          <year>1995</year>
          <fpage>135</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">7723784</pub-id>
        </element-citation>
      </ref>
      <ref id="b0010">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlton</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Mackinnon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>A chloroquine resistance locus in the rodent malaria parasite <italic>Plasmodium chabaudi</italic></article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>93</volume>
          <year>1998</year>
          <fpage>57</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">9662028</pub-id>
        </element-citation>
      </ref>
      <ref id="b0015">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlton</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hayton</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Cravo</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models</article-title>
          <source>Trends Parasitol.</source>
          <volume>17</volume>
          <year>2001</year>
          <fpage>236</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">11323308</pub-id>
        </element-citation>
      </ref>
      <ref id="b0020">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Saul</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance</article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>65</volume>
          <year>1994</year>
          <fpage>361</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">7969277</pub-id>
        </element-citation>
      </ref>
      <ref id="b0025">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Lew</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Chromosomal rearrangements and point mutations in the DHFR-TS gene of <italic>Plasmodium chabaudi</italic> under antifolate selection</article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>42</volume>
          <year>1990</year>
          <fpage>21</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">2233898</pub-id>
        </element-citation>
      </ref>
      <ref id="b0030">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cravo</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Carlton</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bisoni</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Padua</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Genetics of mefloquine resistance in the rodent malaria parasite <italic>Plasmodium chabaudi</italic></article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>47</volume>
          <year>2003</year>
          <fpage>709</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="pmid">12543682</pub-id>
        </element-citation>
      </ref>
      <ref id="b0035">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Culleton</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Linkage group selection: rapid gene discovery in malaria parasites</article-title>
          <source>Genome Res.</source>
          <volume>15</volume>
          <year>2005</year>
          <fpage>92</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">15632093</pub-id>
        </element-citation>
      </ref>
      <ref id="b0040">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahlström</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Veiga</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Mårtensson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Björkman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Polymorphism in PfMRP1 (<italic>Plasmodium falciparum</italic> multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine–pyrimethamine treatment</article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>53</volume>
          <year>2009</year>
          <fpage>2553</fpage>
          <lpage>2556</lpage>
          <pub-id pub-id-type="pmid">19364873</pub-id>
        </element-citation>
      </ref>
      <ref id="b0045">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duraisingh</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Contribution of the <italic>pfmdr1</italic> gene to antimalarial drug-resistance</article-title>
          <source>Acta Trop.</source>
          <volume>94</volume>
          <year>2005</year>
          <fpage>181</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">15876420</pub-id>
        </element-citation>
      </ref>
      <ref id="b0050">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eastham</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Rieckmann</surname>
              <given-names>K.H.</given-names>
            </name>
          </person-group>
          <article-title>The activity of pyrimethamine and sulphadoxine against <italic>Plasmodium falciparum</italic> determined by the in vitro microtechnique</article-title>
          <source>Trans. R. Soc. Trop. Med. Hyg.</source>
          <volume>77</volume>
          <year>1983</year>
          <fpage>91</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">6344364</pub-id>
        </element-citation>
      </ref>
      <ref id="b0055">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ekong</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Warhurst</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant <italic>Plasmodium falciparum</italic></article-title>
          <source>Parasitology</source>
          <volume>106</volume>
          <year>1993</year>
          <fpage>107</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">8446468</pub-id>
        </element-citation>
      </ref>
      <ref id="b0060">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grech</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pathirana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Numerous, robust genetic markers for <italic>Plasmodium chabaudi</italic> by the method of amplified fragment length polymorphism</article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>123</volume>
          <year>2002</year>
          <fpage>95</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">12270625</pub-id>
        </element-citation>
      </ref>
      <ref id="b0065">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gregson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Plowe</surname>
              <given-names>C.V.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of resistance of malaria parasites to antifolates</article-title>
          <source>Pharmacol. Rev.</source>
          <volume>57</volume>
          <year>2005</year>
          <fpage>117</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">15734729</pub-id>
        </element-citation>
      </ref>
      <ref id="b0070">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayton</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ranford-Cartwright</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Sulfadoxine–pyrimethamine resistance in the rodent malaria parasite <italic>Plasmodium chabaudi</italic></article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>46</volume>
          <year>2002</year>
          <fpage>2482</fpage>
          <lpage>2489</lpage>
          <pub-id pub-id-type="pmid">12121922</pub-id>
        </element-citation>
      </ref>
      <ref id="b0075">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hornberg</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Bruggeman</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Westerhoff</surname>
              <given-names>H.V.</given-names>
            </name>
          </person-group>
          <article-title>Metabolic control analysis to identify optimal drug targets</article-title>
          <source>Prog. Drug Res.</source>
          <volume>64</volume>
          <year>2007</year>
          <comment>171, 173–189</comment>
        </element-citation>
      </ref>
      <ref id="b0080">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Modrzynska</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Creasey</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Beraldi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Loewe</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Urmi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Pain</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Blaxter</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cravo</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Experimental evolution, genetic analysis and genome re-sequencing reveals the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites</article-title>
          <source>BMC Genomics.</source>
          <volume>11</volume>
          <year>2010</year>
          <fpage>499</fpage>
          <pub-id pub-id-type="pmid">20846421</pub-id>
        </element-citation>
      </ref>
      <ref id="b0085">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyde</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Exploring the folate pathway in <italic>Plasmodium falciparum</italic></article-title>
          <source>Acta Trop.</source>
          <volume>94</volume>
          <year>2005</year>
          <fpage>191</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">15845349</pub-id>
        </element-citation>
      </ref>
      <ref id="b0090">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobs</surname>
              <given-names>R.L.</given-names>
            </name>
          </person-group>
          <article-title>Role of <italic>p</italic>-aminobenzoic acid in <italic>Plasmodium berghei</italic> infection in the mouse</article-title>
          <source>Exp. Parasitol.</source>
          <volume>15</volume>
          <year>1964</year>
          <fpage>213</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">14191322</pub-id>
        </element-citation>
      </ref>
      <ref id="b0095">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kidgell</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Volkman</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Daily</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Borevitz</surname>
              <given-names>J.O.</given-names>
            </name>
            <name>
              <surname>Plouffe</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Le Roch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sarr</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Ndir</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Mboup</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Batalov</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Winzeler</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>A systematic map of genetic variation in <italic>Plasmodium falciparum</italic></article-title>
          <source>PLoS Pathog.</source>
          <volume>2</volume>
          <year>2006</year>
          <fpage>e57</fpage>
          <pub-id pub-id-type="pmid">16789840</pub-id>
        </element-citation>
      </ref>
      <ref id="b0100">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klokouzas</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shahi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hladky</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Barrand</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>van Veen</surname>
              <given-names>H.W.</given-names>
            </name>
          </person-group>
          <article-title>ABC transporters and drug resistance in parasitic protozoa</article-title>
          <source>Int. J. Antimicrob. Agents</source>
          <volume>22</volume>
          <year>2003</year>
          <fpage>301</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">13678838</pub-id>
        </element-citation>
      </ref>
      <ref id="b0105">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krungkrai</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Yuthavong</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, <italic>Plasmodium falciparum</italic></article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>32</volume>
          <year>1989</year>
          <fpage>25</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">2643036</pub-id>
        </element-citation>
      </ref>
      <ref id="b0110">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Durbin</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Mapping short DNA sequencing reads and calling variants using mapping quality scores</article-title>
          <source>Genome Res.</source>
          <volume>18</volume>
          <year>2008</year>
          <fpage>1851</fpage>
          <lpage>1858</lpage>
          <pub-id pub-id-type="pmid">18714091</pub-id>
        </element-citation>
      </ref>
      <ref id="b0115">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mberu</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Mosobo</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Nzila</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Kokwaro</surname>
              <given-names>G.O.</given-names>
            </name>
            <name>
              <surname>Sibley</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>W.M.</given-names>
            </name>
          </person-group>
          <article-title>The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in <italic>Plasmodium falciparum</italic> field isolates from Kilifi, Kenya</article-title>
          <source>Am. J. Trop. Med. Hyg.</source>
          <volume>62</volume>
          <year>2000</year>
          <fpage>396</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">11037785</pub-id>
        </element-citation>
      </ref>
      <ref id="b0120">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCollum</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Basco</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Tahar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Udhayakumar</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Escalante</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Hitchhiking and selective sweeps of <italic>Plasmodium falciparum</italic> sulfadoxine and pyrimethamine resistance alleles in a population from central Africa</article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>52</volume>
          <year>2008</year>
          <fpage>4089</fpage>
          <lpage>4097</lpage>
          <pub-id pub-id-type="pmid">18765692</pub-id>
        </element-citation>
      </ref>
      <ref id="b0125">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milhous</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Weatherly</surname>
              <given-names>N.F.</given-names>
            </name>
            <name>
              <surname>Bowdre</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Desjardins</surname>
              <given-names>R.E.</given-names>
            </name>
          </person-group>
          <article-title>In vitro activities of and mechanisms of resistance to antifol antimalarial drugs</article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>27</volume>
          <year>1985</year>
          <fpage>525</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">3890727</pub-id>
        </element-citation>
      </ref>
      <ref id="b0130">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nair</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Brockman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Paiphun</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mayxay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Guthmann</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Smithuis</surname>
              <given-names>F.M.</given-names>
            </name>
            <name>
              <surname>Hien</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Nosten</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites</article-title>
          <source>Mol. Biol. Evol.</source>
          <volume>20</volume>
          <year>2003</year>
          <fpage>1526</fpage>
          <lpage>1536</lpage>
          <pub-id pub-id-type="pmid">12832643</pub-id>
        </element-citation>
      </ref>
      <ref id="b0135">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nair</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Millerm</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Barends</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jaideem</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mayxay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nosten</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferdig</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>Adaptive copy number evolution in malaria parasites</article-title>
          <source>PLoS Genet.</source>
          <volume>4</volume>
          <year>2008</year>
          <fpage>e1000243</fpage>
          <pub-id pub-id-type="pmid">18974876</pub-id>
        </element-citation>
      </ref>
      <ref id="b0140">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nash</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mayxay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>P.N.</given-names>
            </name>
            <name>
              <surname>Guthmann</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Nosten</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>Selection strength and hitchhiking around two anti-malarial resistance genes</article-title>
          <source>Proc. Biol. Sci.</source>
          <volume>272</volume>
          <year>2005</year>
          <fpage>1153</fpage>
          <lpage>1161</lpage>
          <pub-id pub-id-type="pmid">16024377</pub-id>
        </element-citation>
      </ref>
      <ref id="b0145">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ning</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Mullikin</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>SSAHA: a fast search method for large DNA databases</article-title>
          <source>Genome Res.</source>
          <volume>11</volume>
          <year>2001</year>
          <fpage>1725</fpage>
          <lpage>1729</lpage>
          <pub-id pub-id-type="pmid">11591649</pub-id>
        </element-citation>
      </ref>
      <ref id="b0150">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nosten</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Artemisinin-based combination treatment of falciparum malaria</article-title>
          <source>Am. J. Trop. Med. Hyg.</source>
          <volume>77</volume>
          <year>2007</year>
          <fpage>181</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">18165491</pub-id>
        </element-citation>
      </ref>
      <ref id="b0155">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nzila</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The past, present and future of antifolates in the treatment of <italic>Plasmodium falciparum</italic> infection</article-title>
          <source>J. Antimicrob. Chemother.</source>
          <volume>57</volume>
          <year>2006</year>
          <fpage>1043</fpage>
          <lpage>1054</lpage>
          <pub-id pub-id-type="pmid">16617066</pub-id>
        </element-citation>
      </ref>
      <ref id="b0160">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nzila-Mounda</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mberu</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Sibley</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Plowe</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Winstanley</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>W.M.</given-names>
            </name>
          </person-group>
          <article-title>Kenyan <italic>Plasmodium falciparum</italic> field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain</article-title>
          <source>Antimicrob. Agents Chemother.</source>
          <volume>42</volume>
          <year>1998</year>
          <fpage>164</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">9449279</pub-id>
        </element-citation>
      </ref>
      <ref id="b0165">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peterson</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wellems</surname>
              <given-names>T.E.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>85</volume>
          <year>1988</year>
          <fpage>9114</fpage>
          <lpage>9118</lpage>
          <pub-id pub-id-type="pmid">2904149</pub-id>
        </element-citation>
      </ref>
      <ref id="b0170">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Plowe</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Cortese</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Djimde</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nwanyanwu</surname>
              <given-names>O.C.</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Winstanley</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Estrada-Franco</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Mollinedo</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Avila</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Cespedes</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Doumbo</surname>
              <given-names>O.K.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in <italic>Plasmodium falciparum</italic> dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine–sulfadoxine use and resistance</article-title>
          <source>J. Infect. Dis.</source>
          <volume>176</volume>
          <year>1997</year>
          <fpage>1590</fpage>
          <lpage>1596</lpage>
          <pub-id pub-id-type="pmid">9395372</pub-id>
        </element-citation>
      </ref>
      <ref id="b0175">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Litus</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Schwarzfuchs</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sinay</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schlesinger</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Golenser</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Baumeister</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lingelbach</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pollack</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>pfmdr2 confers heavy metal resistance to <italic>Plasmodium falciparum</italic></article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>27039</fpage>
          <lpage>27045</lpage>
          <pub-id pub-id-type="pmid">16849328</pub-id>
        </element-citation>
      </ref>
      <ref id="b0180">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubio</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title><italic>Plasmodium falciparum</italic>: the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite</article-title>
          <source>Exp. Parasitol.</source>
          <volume>79</volume>
          <year>1994</year>
          <fpage>137</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">7914495</pub-id>
        </element-citation>
      </ref>
      <ref id="b0185">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rutherford</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Parkhill</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Horsnell</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Rajandream</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Barrell</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Artemis: sequence visualization and annotation</article-title>
          <source>Bioinformatics</source>
          <volume>16</volume>
          <year>2000</year>
          <fpage>944</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">11120685</pub-id>
        </element-citation>
      </ref>
      <ref id="b0190">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauvage</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Aubert</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Escotte-Binet</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Villena</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>The role of ATP-binding cassette (ABC) proteins in protozoan parasites</article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>167</volume>
          <year>2009</year>
          <fpage>81</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">19464325</pub-id>
        </element-citation>
      </ref>
      <ref id="b0195">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sirawaraporn</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sathitkul</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sirawaraporn</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yuthavong</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Santi</surname>
              <given-names>D.V.</given-names>
            </name>
          </person-group>
          <article-title>Antifolate-resistant mutants of <italic>Plasmodium falciparum</italic> dihydrofolate reductase</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>94</volume>
          <year>1997</year>
          <fpage>1124</fpage>
          <lpage>1129</lpage>
          <pub-id pub-id-type="pmid">9037017</pub-id>
        </element-citation>
      </ref>
      <ref id="b0200">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Triglia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Primary structure and expression of the dihydropteroate synthetase gene of <italic>Plasmodium falciparum</italic></article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>91</volume>
          <year>1994</year>
          <fpage>7149</fpage>
          <lpage>7153</lpage>
          <pub-id pub-id-type="pmid">8041761</pub-id>
        </element-citation>
      </ref>
      <ref id="b0205">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Triglia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Menting</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in <italic>Plasmodium falciparum</italic></article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>94</volume>
          <year>1997</year>
          <fpage>13944</fpage>
          <lpage>13949</lpage>
          <pub-id pub-id-type="pmid">9391132</pub-id>
        </element-citation>
      </ref>
      <ref id="b0210">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Triglia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Cowman</surname>
              <given-names>A.F.</given-names>
            </name>
          </person-group>
          <article-title>Allelic exchange at the endogenous genomic locus in <italic>Plasmodium falciparum</italic> proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria</article-title>
          <source>EMBO J.</source>
          <volume>17</volume>
          <year>1998</year>
          <fpage>3807</fpage>
          <lpage>3815</lpage>
          <pub-id pub-id-type="pmid">9669998</pub-id>
        </element-citation>
      </ref>
      <ref id="b0215">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walliker</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sanderson</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Genetic studies on <italic>Plasmodium chabaudi</italic>: recombination between enzyme markers</article-title>
          <source>Parasitology</source>
          <volume>70</volume>
          <year>1975</year>
          <fpage>19</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">1118185</pub-id>
        </element-citation>
      </ref>
      <ref id="b0220">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Read</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Sulfadoxine resistance in the human malaria parasite <italic>Plasmodium falciparum</italic> is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization</article-title>
          <source>Mol. Microbiol.</source>
          <volume>23</volume>
          <year>1997</year>
          <fpage>979</fpage>
          <lpage>986</lpage>
          <pub-id pub-id-type="pmid">9076734</pub-id>
        </element-citation>
      </ref>
      <ref id="b0225">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Brobey</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Horii</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>P.F.</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Utilization of exogenous folate in the human malaria parasite <italic>Plasmodium falciparum</italic> and its critical role in antifolate drug synergy</article-title>
          <source>Mol. Microbiol.</source>
          <volume>32</volume>
          <year>1999</year>
          <fpage>1254</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="pmid">10383765</pub-id>
        </element-citation>
      </ref>
      <ref id="b0230">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kirkman</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Wellems</surname>
              <given-names>T.E.</given-names>
            </name>
          </person-group>
          <article-title>Transformation of <italic>Plasmodium falciparum</italic> malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>93</volume>
          <year>1996</year>
          <fpage>1130</fpage>
          <lpage>1134</lpage>
          <pub-id pub-id-type="pmid">8577727</pub-id>
        </element-citation>
      </ref>
      <ref id="b0235">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wurtz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Briolant</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parquet</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Baret</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Amalvict</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Almeras</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rogier</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pradines</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene</article-title>
          <source>J. Antimicrob. Chemother.</source>
          <volume>65</volume>
          <year>2010</year>
          <fpage>1387</fpage>
          <lpage>1394</lpage>
          <pub-id pub-id-type="pmid">20501488</pub-id>
        </element-citation>
      </ref>
      <ref id="b0240">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zalis</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>D.F.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the pfmdr2 gene for <italic>Plasmodium falciparum</italic></article-title>
          <source>Mol. Biochem. Parasitol.</source>
          <volume>62</volume>
          <year>1993</year>
          <fpage>83</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">8114829</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0065" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <fig id="f0010" position="anchor">
          <label>Supplementary Fig. 1</label>
          <caption>
            <p>Folate pathway in <italic>Plasmodium</italic> parasites. Pyrimethamine (PYR) and sulphadoxine (SDX) inhibit dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS), respectively. 4-Aminobenzoic acid (pPABA) (competitive binding with SDX) is a substrate for DHPS. Both pPABA and folate may be acquired from the host. pPABA may also be produced endogenously via the shikimate pathway. Host folate may mediate a ‘folate effect’ and hence alleviate the inhibitory action of SDX and, to a lesser extent, PYR. <italic>6-pthps</italic>, 6-pyruvoyltetrahydropterin synthase; <italic>gtpch</italic>, GTP cyclohydrolase I; <italic>pppk</italic>, dihydropterin pyrophosphokinase; <italic>dhps</italic>, dihydropteroate synthase; <italic>dhfs</italic>, dihydrofolate synthase; <italic>dhfr</italic>, dihydrofolate reductase; <italic>shmt</italic>, serine hydroxymethyltransferase; <italic>ts</italic>, thymidylate synthase.</p>
          </caption>
          <graphic xlink:href="fx2"/>
        </fig>
        <fig id="f0015" position="anchor">
          <label>Supplementary Fig. S2</label>
          <caption>
            <p>Distribution of the intervals for the paired-end reads of the <italic>Plasmodium chabaudi</italic> clone AS-50S/P.</p>
          </caption>
          <graphic xlink:href="fx3"/>
        </fig>
        <fig id="f0020" position="anchor">
          <label>Supplementary Fig. S3</label>
          <caption>
            <p>Positions of markers and genes on <italic>Plasmodium chabaudi</italic> chromosome 13. Multi-drug resistant protein 2 (<italic>mdr2</italic>), fructose-bisphosphate aldolase (<italic>aldoI</italic>) and glucose-6-phosphate dehydrogenase (<italic>g6pdh</italic>) are indicated. Numerical values next to gene acronyms indicate the level of linkage (mean difference in log parasitaemia) of the parental allele with sulphadoxine (SDX) response, as calculated by <xref rid="b0070" ref-type="bibr">Hayton et al. (2002)</xref>. The asterisk indicates that linkage is statistically significant (<italic>P</italic> &lt; 0.05).</p>
          </caption>
          <graphic xlink:href="fx4"/>
        </fig>
        <supplementary-material content-type="local-data" id="m0005">
          <caption>
            <title>Supplementary Table S1</title>
            <p>All mutations identified uniquely in the <italic>Plasmodium chabaudi</italic> clone AS-50S/P following whole genome re-sequencing analysis. Column “P” provides the current status of mutations: highlighted in green are confirmed mutations, highlighted in yellow are high confidence putative mutations (based on the quality scores in column “O”), highlighted in orange are low confidence putative mutations, while red indicates false positives, i.e., putative mutations rejected after di-deoxy sequencing. This list includes lower confidence (highlighted in orange) potential indels. Read depth, base quality scores and indel quality scores were based on Sequence Search and Alignment by Hashing Algorithm (SSAHA2).</p>
          </caption>
          <media xlink:href="mmc1.xls" mimetype="application" mime-subtype="vnd.ms-excel"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>A.M. and G.H. were supported by the Fundação para a Ciência e a Tecnologia (FCT) of Portugal (Grant nos.: SFRH/BPD/35017/2007 and SFRH/BD/63129/2009, respectively). P.H. was funded by the Wellcome Trust Centre-in-Development in Immunity, Infection and Evolution (UK) (082611/Z/07/Z). Medical Research Council, UK (G0400476) and FCT (project no. PTDC/SAU-MII/65028/2006) supported the research. We thank Karen Hayton (National Institutes of Health, USA) for experimental details, and Thomas D. Otto (Wellcome Trust Sanger Institute, UK) for assistance with use of SSAHA2. Access to the <italic>P. chabaudi</italic> genome assembly was provided by the Pathogen Sequencing Unit at the Wellcome Trust Sanger Institute, UK and can be obtained from ftp://ftp.sanger.ac.uk/pub/pathogens/P_chabaudi/September_2009_assembly/.</p>
    </ack>
    <fn-group>
      <fn id="d30e876">
        <label>☆</label>
        <p><italic>Note:</italic> Nucleotide sequence data reported in this paper have been submitted to the PlasmoDB database.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>AS lineage of the <italic>Plasmodium chabaudi</italic> parasite clones used in the study. The lineage progenitor clone AS-sens was selected for pyrimethamine (PYR) resistance, giving rise to AS-PYR. Subsequently, AS-PYR was selected for sulphadoxine (SDX)/PYR (S/P) resistance, resulting in clone AS-50S/P with reduced susceptibility to SDX. AS-sens was also used to generate the current reference genome for <italic>P. chabaudi</italic>. The reference genome is termed AS-WTSI; dotted lines represent possible divergence due to passage history. Verified mutations are indicated. Dihydrofolate reductase (<italic>dhfr</italic>), chromosome (chr), multi-drug resistance protein 2 gene (<italic>mdr2</italic>).</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <table-wrap id="t0005" position="float" orientation="landscape">
      <?landscape?>
      <?legal?>
      <label>Table 1</label>
      <caption>
        <p>Summary table of all mutations (single nucleotide polymorphisms (SNPs) and indels) identified in the <italic>Plasmodium chabaudi</italic> clone AS-50S/P using the Mapping and Assembly with Quality (MAQ) and Sequence Search and Alignment by Hashing Algorithm (SSAHA2) softwares. The status of each mutation is highlighted in bold letters. “YES” indicates confirmed mutations, “high” indicates non-confirmed high confidence putative mutations (based on quality scores), “low” indicates non-confirmed low confidence putative mutations, while “NO” indicates false positives rejected after di-deoxy sequencing. Only confirmed (“YES”), rejected (“NO”) and high confidence (“high”) mutations are shown for indels and copy number variations (CNVs), whereas low confidence (expected to be negated) SNPs (“low”) are also shown. Base quality scores and indel quality scores were based on SSAHA2.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Chr’some</th>
            <th>Type</th>
            <th>Analysis</th>
            <th>Start (indels only)</th>
            <th>End</th>
            <th>Reference base</th>
            <th>Base in AS-50SP</th>
            <th>Base/indel quality</th>
            <th>Confirmation of mutation by di-deoxy sequencing</th>
            <th><italic>P. chabaudi</italic> gene ID</th>
            <th>aa change</th>
            <th><italic>P. chabaudi</italic> nearest gene ID</th>
            <th><italic>Plasmodium falciparum</italic> orthologue</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td/>
            <td colspan="2">
              <italic>Putative SNPs</italic>
            </td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>2</td>
            <td>SNP</td>
            <td>MAQ/SSAHA</td>
            <td/>
            <td align="char">200,295</td>
            <td>T</td>
            <td>C</td>
            <td>99</td>
            <td>YES</td>
            <td>PCHAS_020660</td>
            <td>E109G</td>
            <td/>
            <td>PFA0250w</td>
          </tr>
          <tr>
            <td>7</td>
            <td>SNP</td>
            <td>MAQ/SSAHA</td>
            <td/>
            <td align="char">994,546</td>
            <td>G</td>
            <td>A</td>
            <td>99</td>
            <td>YES</td>
            <td>PCHAS_072830</td>
            <td>S106 N</td>
            <td/>
            <td>PFD0830w</td>
          </tr>
          <tr>
            <td>13</td>
            <td>SNP</td>
            <td>MAQ/SSAHA</td>
            <td/>
            <td align="char">613,601</td>
            <td>T</td>
            <td>G</td>
            <td>47</td>
            <td>YES</td>
            <td>PCHAS_131500</td>
            <td>K392Q</td>
            <td/>
            <td>PF14_0455</td>
          </tr>
          <tr>
            <td>14</td>
            <td>SNP</td>
            <td>SSAHA</td>
            <td/>
            <td align="char">711,800</td>
            <td>T</td>
            <td>G</td>
            <td>37</td>
            <td>NO</td>
            <td/>
            <td/>
            <td>5-PCHAS_141940</td>
            <td>PF13_0106</td>
          </tr>
          <tr>
            <td>14</td>
            <td>SNP</td>
            <td>MAQ/SSAHA</td>
            <td/>
            <td align="char">936,945</td>
            <td>T</td>
            <td>G</td>
            <td>40</td>
            <td>YES</td>
            <td/>
            <td/>
            <td>5-PCHAS_142600</td>
            <td>PF08_0081</td>
          </tr>
          <tr>
            <td>14</td>
            <td>SNP</td>
            <td>SSAHA</td>
            <td/>
            <td align="char">951,458</td>
            <td>T</td>
            <td>A</td>
            <td>10</td>
            <td>NO</td>
            <td/>
            <td/>
            <td>5-PCHAS_142640</td>
            <td>PF08_0083</td>
          </tr>
          <tr>
            <td>bin</td>
            <td>SNP</td>
            <td>SSAHA</td>
            <td/>
            <td align="char">107,354</td>
            <td>A</td>
            <td>C</td>
            <td>25</td>
            <td>low</td>
            <td>PCHAS_000260</td>
            <td/>
            <td/>
            <td>None</td>
          </tr>
          <tr>
            <td>bin</td>
            <td>SNP</td>
            <td>SSAHA</td>
            <td/>
            <td align="char">411,999</td>
            <td>T</td>
            <td>C</td>
            <td>14</td>
            <td>low</td>
            <td/>
            <td/>
            <td>PCHAS_001050-3</td>
            <td>None</td>
          </tr>
          <tr>
            <td colspan="13">  </td>
          </tr>
          <tr>
            <td/>
            <td colspan="2">
              <italic>Putative indels</italic>
            </td>
            <td/>
            <td/>
            <td>
              <italic>Size</italic>
            </td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td>2</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">378,527</td>
            <td align="char">378,527</td>
            <td>1</td>
            <td/>
            <td>8/12</td>
            <td>high</td>
            <td>PCHAS_021100</td>
            <td/>
            <td/>
            <td>MAL7P1.154a</td>
          </tr>
          <tr>
            <td>3</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">409,429</td>
            <td align="char">409,429</td>
            <td>1</td>
            <td/>
            <td>6/10</td>
            <td>high</td>
            <td>PCHAS_031150</td>
            <td/>
            <td/>
            <td>PFB0560w</td>
          </tr>
          <tr>
            <td>7</td>
            <td>Deletion</td>
            <td>SSAHA</td>
            <td align="char">779,270</td>
            <td align="char">779,270</td>
            <td>1</td>
            <td/>
            <td>120/46</td>
            <td>high</td>
            <td>PCHAS_072120</td>
            <td/>
            <td/>
            <td>MAL8P1.65</td>
          </tr>
          <tr>
            <td>7</td>
            <td>Deletion</td>
            <td>SSAHA</td>
            <td align="char">876,894</td>
            <td align="char">876,927</td>
            <td>34</td>
            <td/>
            <td/>
            <td>YES</td>
            <td/>
            <td/>
            <td>PCHAS_072420-3</td>
            <td>PF08_0067</td>
          </tr>
          <tr>
            <td>8</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">854,448</td>
            <td align="char">854,448</td>
            <td>1</td>
            <td/>
            <td>2/4</td>
            <td>NO</td>
            <td>PCHAS_082240</td>
            <td/>
            <td/>
            <td>PFI1065c</td>
          </tr>
          <tr>
            <td>9</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">60,998</td>
            <td align="char">60,998</td>
            <td>1</td>
            <td/>
            <td>10/11</td>
            <td>high</td>
            <td/>
            <td/>
            <td>PCHAS_090150-5</td>
            <td>PF11_0052</td>
          </tr>
          <tr>
            <td>9</td>
            <td>Deletion</td>
            <td>SSAHA</td>
            <td align="char">1113,660</td>
            <td align="char">1113,660</td>
            <td>1</td>
            <td/>
            <td>23/24</td>
            <td>high</td>
            <td>PCHAS_093250</td>
            <td/>
            <td/>
            <td>PF11_0361</td>
          </tr>
          <tr>
            <td>10</td>
            <td>Deletion</td>
            <td>SSAHA/MAQ</td>
            <td align="char">290,663</td>
            <td align="char">290,663</td>
            <td>1</td>
            <td/>
            <td>26/31</td>
            <td>NO</td>
            <td/>
            <td/>
            <td>3-PCHAS_100680</td>
            <td>PFD0460c</td>
          </tr>
          <tr>
            <td>11</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">694,180</td>
            <td align="char">694,180</td>
            <td>1</td>
            <td/>
            <td>98/142</td>
            <td>high</td>
            <td/>
            <td/>
            <td>3-PCHAS_111970</td>
            <td>PFF1025c</td>
          </tr>
          <tr>
            <td>13</td>
            <td>Insert</td>
            <td>SSAHA</td>
            <td align="char">1703,059</td>
            <td align="char">1703,059</td>
            <td>1</td>
            <td/>
            <td>48/33</td>
            <td>high</td>
            <td/>
            <td/>
            <td>PCHAS_134540-5</td>
            <td>MAL13P1.139a</td>
          </tr>
          <tr>
            <td>bin</td>
            <td>Deletion</td>
            <td>SSAHA</td>
            <td align="char">262,255</td>
            <td align="char">262,255</td>
            <td>1</td>
            <td/>
            <td>20/18</td>
            <td>high</td>
            <td/>
            <td/>
            <td>5-PCHAS_000700</td>
            <td>None</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>aa, Amino acid.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t0010" position="float">
      <label>Table 2</label>
      <caption>
        <p>Gene copy number by Solexa sequencing fold-coverage analysis. Comparative coverage (bold) gives an estimate of gene copy number for genes of the folate biosynthetic pathway and multi-drug resistance protein 1 (<italic>mdr1</italic>) in the <italic>Plasmodium chabaudi</italic> mutant clone AS-50S/P and wild-type clone AS-sens. Comparative coverage gives a reliable estimate of gene copy number as shown for the <italic>mdr1</italic> gene in mutant clone AS-15MF. <italic>mdr1</italic>, multi-drug resistance 1; <italic>gtpch</italic>, GTP cyclohydrolase I; <italic>dhfr</italic>, dihydrofolate reductase; <italic>dhps</italic>, dihydropteroate synthase; <italic>dhfs</italic>, dihydrofolate synthase; <italic>6-pthps</italic>, 6-pyruvoyltetrahydropterin synthase; <italic>shmt,</italic> serine hydroxymethyltransferase.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="2">Mutant clone</th>
            <th rowspan="2">Gene</th>
            <th colspan="2">Mean coverage<xref rid="tblfn1" ref-type="table-fn">a</xref><hr/></th>
            <th colspan="2">Relative coverage<xref rid="tblfn2" ref-type="table-fn">b</xref><hr/></th>
            <th rowspan="2">Comparative coverage in mutant clone<xref rid="tblfn3" ref-type="table-fn">c</xref></th>
          </tr>
          <tr>
            <th>AS-sens</th>
            <th>Mutant clone</th>
            <th>AS-sens</th>
            <th>Mutant clone</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="8">AS-50S/P</td>
            <td>Genome<xref rid="tblfn4" ref-type="table-fn">d</xref></td>
            <td align="char">39.48</td>
            <td align="char">44.44</td>
            <td align="char">1.00</td>
            <td align="char">1.00</td>
            <td align="char">
              <bold>1.00</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>mdr1</italic>
            </td>
            <td align="char">53.39</td>
            <td align="char">74.59</td>
            <td align="char">1.35</td>
            <td align="char">1.68</td>
            <td align="char">
              <bold>1.24</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>gtpch</italic>
            </td>
            <td align="char">45.31</td>
            <td align="char">34.77</td>
            <td align="char">1.15</td>
            <td align="char">0.78</td>
            <td align="char">
              <bold>0.68</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>dhfr</italic>
            </td>
            <td align="char">46.01</td>
            <td align="char">45.48</td>
            <td align="char">1.17</td>
            <td align="char">1.02</td>
            <td align="char">
              <bold>0.88</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>dhps</italic>
            </td>
            <td align="char">45.03</td>
            <td align="char">45.78</td>
            <td align="char">1.14</td>
            <td align="char">1.03</td>
            <td align="char">
              <bold>0.90</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>dhfs</italic>
            </td>
            <td align="char">48.71</td>
            <td align="char">49.76</td>
            <td align="char">1.23</td>
            <td align="char">1.12</td>
            <td align="char">
              <bold>0.91</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>6-pthps</italic>
            </td>
            <td align="char">55.96</td>
            <td align="char">54.28</td>
            <td align="char">1.42</td>
            <td align="char">1.22</td>
            <td align="char">
              <bold>0.86</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>shmt</italic>
            </td>
            <td align="char">52.43</td>
            <td align="char">66.62</td>
            <td align="char">1.33</td>
            <td align="char">1.50</td>
            <td align="char">
              <bold>1.13</bold>
            </td>
          </tr>
          <tr>
            <td colspan="7">  </td>
          </tr>
          <tr>
            <td rowspan="2">AS-15MF</td>
            <td>Genome<xref rid="tblfn4" ref-type="table-fn">d</xref></td>
            <td align="char">39.48</td>
            <td align="char">53.96</td>
            <td align="char">1.00</td>
            <td align="char">1.00</td>
            <td align="char">
              <bold>1.00</bold>
            </td>
          </tr>
          <tr>
            <td>
              <italic>mdr1</italic>
            </td>
            <td align="char">52.39</td>
            <td align="char">150.02</td>
            <td align="char">1.33</td>
            <td align="char">2.78</td>
            <td align="char">
              <bold>2.10</bold>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Mean coverage is the mean number of reads for all bases within the coding region of the genome or gene.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn2">
          <label>b</label>
          <p>Relative coverage equals mean coverage of the gene divided by mean coverage for the whole genome.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn3">
          <label>c</label>
          <p>Comparative coverage is the relative coverage of the mutant clone gene divided by the relative coverage of wild-type AS-sens gene. See Section <xref rid="s0010" ref-type="sec">2</xref> for details.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tblfn4">
          <label>d</label>
          <p>Mean read coverage across the whole genome, excluding unassigned contigs.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>